These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 12042297)

  • 1. Models of cost-effectiveness of recombinant FSH versus urinary FSH.
    Al-Inany H; Afnan M
    Hum Reprod; 2002 Jun; 17(6):1671-3; author reply 1673-4. PubMed ID: 12042297
    [No Abstract]   [Full Text] [Related]  

  • 2. Reflections on the cost-effectiveness of recombinant FSH in assisted reproduction. The clinician's perspective.
    Balasch J; Barri PN
    J Assist Reprod Genet; 2001 Feb; 18(2):45-55. PubMed ID: 11285980
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of the cost effectiveness of recombinant versus urinary follicle-stimulating hormone in in vitro fertilization/intracytoplasmic sperm injection programs in the United States.
    Silverberg K; Daya S; Auray JP; Duru G; Ledger W; Wikland M; Bouzayen R; O'Brien M; Falk B; Beresniak A
    Fertil Steril; 2002 Jan; 77(1):107-13. PubMed ID: 11779599
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Issues of bioequivalence and cost equivalence.
    Mahutte NG; Arici A; Duleba A
    Fertil Steril; 2002 Aug; 78(2):439-40; author reply 440. PubMed ID: 12137897
    [No Abstract]   [Full Text] [Related]  

  • 5. Issues of bioequivalence and cost equivalence.
    Al-Inany HG
    Fertil Steril; 2002 Aug; 78(2):438; author reply 438-9. PubMed ID: 12137895
    [No Abstract]   [Full Text] [Related]  

  • 6. [Effect of domestic highly purified urinary follicle stimulating hormone on outcomes of in vitro fertilization-embryo transfer in controlled ovarian stimulation].
    Ye H; Huang GN; Cao YX; Zhong Y; Huang YH; Zhu GJ; Zhou LM; Chen ZJ; Shi JZ; Zeng Y; Weng N; Huang XF; Yang J; Zhu YM; Li YP; Yi D; Zhuang GL
    Zhonghua Fu Chan Ke Za Zhi; 2013 Nov; 48(11):838-42. PubMed ID: 24444561
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recombinant versus urinary follicle-stimulating hormone in intrauterine insemination cycles: a prospective, randomized analysis of cost effectiveness.
    Gerli S; Casini ML; Unfer V; Costabile L; Bini V; Di Renzo GC
    Fertil Steril; 2004 Sep; 82(3):573-8. PubMed ID: 15374698
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Markov model of the cost-effectiveness of human-derived follicle-stimulating hormone (FSH) versus recombinant FSH using comparative clinical trial data.
    Hatoum HT; Keye WR; Marrs RP; Walton SM; Marshall DC
    Fertil Steril; 2005 Mar; 83(3):804-7. PubMed ID: 15749525
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Costs and outcomes associated with IVF using recombinant FSH.
    Ledger W; Wiebinga C; Anderson P; Irwin D; Holman A; Lloyd A
    Reprod Biomed Online; 2009 Sep; 19(3):337-42. PubMed ID: 19778478
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Meta-analysis of recombinant FSH and urinary-derived gonadotrophins for IVF or ICSI.
    van Wely M; van der Veen F
    Hum Reprod; 2003 Jul; 18(7):1554-5; author reply 1555-6. PubMed ID: 12832388
    [No Abstract]   [Full Text] [Related]  

  • 11. Recombinant or urinary follicle-stimulating hormone? A cost-effectiveness analysis derived by particularizing the number needed to treat from a published meta-analysis.
    Ola B; Papaioannou S; Afnan MA; Hammadieh N; Gimba S
    Fertil Steril; 2001 Jun; 75(6):1106-10. PubMed ID: 11384634
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost-effectiveness of recombinant versus urinary follicle stimulating hormone; whose point of view?
    Ola B; Afnan M; Sharif K; Hammadieh N; Papaioannou S; Coomarasamy A
    Acta Obstet Gynecol Scand; 2001 Dec; 80(12):1141-2. PubMed ID: 11846714
    [No Abstract]   [Full Text] [Related]  

  • 13. Prospective, randomized study comparing highly purified urinary follicle-stimulating hormone (FSH) and recombinant FSH for in vitro fertilization/intracytoplasmic sperm injection in patients with polycystic ovary syndrome.
    Aboulghar M; Saber W; Amin Y; Aboulghar M; Mansour R; Serour G
    Fertil Steril; 2010 Nov; 94(6):2332-4. PubMed ID: 20188364
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A prospective, randomized, assessor-blind, multicentre study comparing recombinant and urinary follicle stimulating hormone (Puregon versus Metrodin) in in-vitro fertilization.
    Out HJ; Mannaerts BM; Driessen SG; Bennink HJ
    Hum Reprod; 1995 Oct; 10(10):2534-40. PubMed ID: 8567765
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmaco-economic aspects of in-vitro fertilization in Italy.
    Mantovani LG; Belisari A; Szucs TD
    Hum Reprod; 1999 Apr; 14(4):953-8. PubMed ID: 10221226
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An economic evaluation of highly purified HMG and recombinant FSH based on a large randomized trial.
    Wechowski J; Connolly M; McEwan P; Kennedy R
    Reprod Biomed Online; 2007 Nov; 15(5):500-6. PubMed ID: 18028739
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Economic Evaluation of Three Frequently Used Gonadotrophins in Assisted Reproduction Techniques in the Management of Infertility in the Netherlands.
    Fragoulakis V; Pescott CP; Smeenk JM; van Santbrink EJ; Oosterhuis GJ; Broekmans FJ; Maniadakis N
    Appl Health Econ Health Policy; 2016 Dec; 14(6):719-727. PubMed ID: 27581117
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of urinary FSH price: a cost-effectiveness analysis of recombinant and urinary FSH in assisted reproduction techniques in the USA.
    Silverberg K; Schertz J; Falk B; Beresniak A
    Reprod Biomed Online; 2002; 5(3):265-9. PubMed ID: 12470524
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [In vitro fertilization in France: economic aspects and influence of the gonadotropin choice (urinary vs. recombinant) on cost].
    de Mouzon J; Allavena E; Schmitt C; Frappé M
    Gynecol Obstet Fertil; 2004 Jun; 32(6):508-18. PubMed ID: 15217566
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Pharmacoeconomic advantages of recombinant FSH vs urinary derived FSH].
    Beresniak A
    Gynecol Obstet Fertil; 2004 Sep; 32(9):756-9. PubMed ID: 15380758
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.